NCT05077020

Brief Summary

For many reasons, medical monitoring in autistic patients is very difficult. This study is designed to determine the prevalence of comorbid diseases (neurological, cardiac, digestive, dental diseases…) in patients suffering from ASD to prevent them or diagnose them earlier.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
27

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jan 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2020

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2021

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2021

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

October 11, 2021

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 13, 2021

Completed
Last Updated

October 26, 2021

Status Verified

October 1, 2021

Enrollment Period

1 year

First QC Date

October 11, 2021

Last Update Submit

October 18, 2021

Conditions

Autistic Spectrum DisorderSomatic Disorders

Outcome Measures

Primary Outcomes (1)

  • Determine the prevalence of comorbid diseases

    Determine the prevalence of comorbid diseases

    1 day

Eligibility Criteria

AgeUp to 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Children followed by psychiatrists in Montpellier university hospital refered to a somatic pediatrician

You may qualify if:

  • \- consultation after psychiatric evaluation

You may not qualify if:

  • age \> 18 years
  • Impossibility to obtain the consent of parents / legal representatives.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Uhmontpellier

Montpellier, 34295, France

Location

MeSH Terms

Conditions

Autism Spectrum Disorder

Condition Hierarchy (Ancestors)

Child Development Disorders, PervasiveNeurodevelopmental DisordersMental Disorders

Study Officials

  • Eric JEZIORSKI

    University Hospital, Montpellier

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 11, 2021

First Posted

October 13, 2021

Study Start

January 1, 2020

Primary Completion

January 1, 2021

Study Completion

October 1, 2021

Last Updated

October 26, 2021

Record last verified: 2021-10

Locations

FR(1)